{"disease":{"id":"elevated-cardiovascular-risk","name":"elevated cardiovascular risk"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05630885","title":"A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04838457","title":"Telehealth Treatment of Veterans With Alcohol Misuse at Risk for Cardiovascular Disease","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT04088240","title":"Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease","phase":"NA","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"University of Arizona","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}